Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial von Patel, Manish R, Ellerton, John, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael, Aljumaily, Raid, Britten, Carolyn D, Dirix, Luc, Lee, Keun-Wook, Taylor, Mathew, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Gelb, Arnold B, Xiong, Junyuan, Rosen, Galit, Gulley, James L, Apolo, Andrea B

Volltext

Anti–Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development von Powles, Thomas, Necchi, Andrea, Rosen, Galit, Hariharan, Subramanian, Apolo, Andrea B.

Volltext

Metabolic syndrome in pediatric cancer survivors: A mechanistic review von Rosen, Galit P., Nguyen, Hoai-Trinh, Shaibi, Gabriel Q.

Volltext

Vitamin D levels differ by cancer diagnosis and decline over time in survivors of childhood cancer von Rosen, Galit P., Beebe, Kristen L., Shaibi, Gabriel Q.

Volltext

Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation von Gaillard, Coline, Tokuyasu, Taku A, Rosen, Galit, Sotzen, Jason, Vitaliano-Prunier, Adeline, Roy, Ritu, Passegué, Emmanuelle, de Thé, Hugues, Figueroa, Maria E, Kogan, Scott C

Volltext

P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE von Rubnitz, Jeffrey, C. Issa, Ghayas, M. Stein, Eytan, Shukla, Neerav, Stock, Wendy, Žučenka, Andrius, Khazal, Sajad, Khera, Nandita, Stieglitz, Elliot, Rubinstein, Jeremy, Rosen, Galit, Ghiraldi, Rachel, Van Nguyen, Huy, Mcneer, Nicole, Zwaan, C. Michel

Volltext

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution von Rosen, Galit P, Nielsen, Karin, Glenn, Sungching, Abelson, Jon, Deville, Jaime, Moore, Theodore B

Volltext

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia von Issa, Ghayas C., Aldoss, Ibrahim, DiPersio, John, Cuglievan, Branko, Stone, Richard, Arellano, Martha, Thirman, Michael J., Patel, Manish R., Dickens, David S., Shenoy, Shalini, Shukla, Neerav, Kantarjian, Hagop, Armstrong, Scott A., Perner, Florian, Perry, Jennifer A., Rosen, Galit, Bagley, Rebecca G., Meyers, Michael L., Ordentlich, Peter, Gu, Yu, Kumar, Vinit, Smith, Steven, McGeehan, Gerard M., Stein, Eytan M.

Volltext

LDL Discordance in Pediatric Survivors of Acute Lymphoblastic Leukemia von Rosen, Galit, Shaibi, Gabriel Q

Volltext

BOS-371, a monoclonal antibody against IL1RAP: Characterization in preclinical models of AML von West, Kip A, Kumar, Sanjay, Scott, Martin, Emery, John G, Steidl, Ulrich G, Narayanagari, Swathi-Rao, Mitchell, Kelly, Ren, Fang, Ying, Hua, Fei, Qi, Yang, Teddy, Svensson, Eric, Rosen, Galit

Volltext

Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101) von Stein, Eytan M., Aldoss, Ibrahim, DiPersio, John F., Stone, Richard M., Arellano, Martha L., Rosen, Galit, Meyers, Michael L., Huang, Yifan, Smith, Steve, Bagley, Rebecca G., Thirman, Michael, Patel, Manish R., Issa, Ghayas C.

Volltext

The menin inhibitor revumenib in KMT2-Arearranged or NPM1-mutant leukaemia von Issa, Ghayas C, Aldoss, Ibrahim, DiPersio, John, Cuglievan, Branko, Stone, Richard, Arellano, Martha, Thirman, Michael J, Patel, Manish R, Dickens, David S, Shenoy, Shalini, Shukla, Neerav, Kantarjian, Hagop, Armstrong, Scott A, Perner, Florian, Perry, Jennifer A, Rosen, Galit, Bagley, Rebecca G, Meyers, Michael L, Ordentlich, Peter, Gu, Yu, Kumar, Vinit, Smith, Steven, McGeehan, Gerard M, Stein, Eytan M

Volltext

Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience von Issa, Ghayas C., Cuglievan, Branko, Stein, Eytan, Arellano, Martha L., Žucenka, Andrius, Khera, Nandita, Stone, Richard M., Thirman, Michael J., DiPersio, John F., Karras, Nicole, Gu, Yu, Bagley, Rebecca G., Rosen, Galit, Tamang, David, Dishman, Kimberly, Scalera, Sushama, Meyers, Michael L., Madigan, Kate, McNeer, Nicole, Aldoss, Ibrahim

Volltext

The Menin Inhibitor SNDX-5613 (revumenib) Leads to Durable Responses in Patients (Pts) with KMT2A-Rearranged or NPM1 Mutant AML: Updated Results of a Phase (Ph) 1 Study von Issa, Ghayas C., Aldoss, Ibrahim, DiPersio, John F., Cuglievan, Branko, Stone, Richard M., Arellano, Martha L., Thirman, Michael J., Patel, Manish R., Dickens, David, Shenoy, Shalini, Shukla, Neerav, Rosen, Galit, Bagley, Rebecca G., Meyers, Michael L., Madigan, Kate, Ordentlich, Peter, Gu, Yu, Smith, Steven, McGeehan, Gerard M., Stein, Eytan

Volltext

Avelumab treatment in metastatic urothelial carcinoma: Association between early response and durable outcomes in the phase Ib JAVELIN Solid Tumor Study von Patel, Manish R., Gulley, James L., Lee, Keun-Wook, Infante, Jeffrey R., Manitz, Juliane, Kasturi, Vijay, Zhang, Hao, Rosen, Galit, Apolo, Andrea B.

Volltext

Avelumab treatment in metastatic urothelial carcinoma: Post-hoc analysis of high-risk populations in the phase Ib JAVELIN Solid Tumor Study von Apolo, Andrea B., Patel, Manish R., Ellerton, John Allan, Dirix, Luc, Manitz, Juliane, Kasturi, Vijay, Warth, John, Rosen, Galit, Gulley, James L.

Volltext

Avelumab treatment for metastatic urothelial carcinoma in the phase Ib JAVELIN Solid Tumor Study: Updated safety and efficacy analysis with ≥ two years of follow-up von Apolo, Andrea B., Ellerton, John Allan, Infante, Jeffrey R., Agrawal, Manish, Gordon, Michael S., Aljumaily, Raid, Britten, Carolyn D., Dirix, Luc, Lee, Keun-Wook, Taylor, Matthew H., Schoffski, Patrick, Wang, Ding, Ravaud, Alain, Xiong, Junyuan, Rosen, Galit, Gulley, James L., Patel, Manish R.

Volltext

Metabolic syndrome in pediatric cancer survivors: A mechanistic review: Metabolic Syndrome in Cancer Survivors von Rosen, Galit P., Nguyen, Hoai-Trinh, Shaibi, Gabriel Q.

Volltext

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial von Patel, Manish R, Ellerton, John, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael, Aljumaily, Raid, Britten, Carolyn D, Dirix, Luc, Lee, Keun-Wook, Taylor, Mathew, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Gelb, Arnold B, Xiong, Junyuan, Rosen, Galit, Gulley, James L, Apolo, Andrea B

Volltext

Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study von Apolo, Andrea B., Ellerton, John Allan, Infante, Jeffrey R., Agrawal, Manish, Gordon, Michael S., Aljumaily, Raid, Britten, Carolyn D., Dirix, Luc Yves, Lee, Keun-Wook, Taylor, Matthew H., Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Gelb, Arnold, Xiong, Junyuan, Rosen, Galit, Patel, Manish R.

Volltext